- Home
- TJX vs GILD Comparison
TJX vs GILD Comparison
Compare TJX & GILD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TJX
- GILD
- Stock Information
- Founded
- TJX 1962
- GILD 1987
- Country
- TJX United States
- GILD United States
- Employees
- TJX N/A
- GILD N/A
- Industry
- TJX Clothing/Shoe/Accessory Stores
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TJX Consumer Discretionary
- GILD Health Care
- Exchange
- TJX Nasdaq
- GILD Nasdaq
- Market Cap
- TJX 134.1B
- GILD 131.5B
- IPO Year
- TJX N/A
- GILD 1992
- Fundamental
- Price
- TJX $127.62
- GILD $104.54
- Analyst Decision
- TJX Strong Buy
- GILD Buy
- Analyst Count
- TJX 17
- GILD 27
- Target Price
- TJX $135.76
- GILD $105.32
- AVG Volume (30 Days)
- TJX 7.1M
- GILD 10.4M
- Earning Date
- TJX 05-21-2025
- GILD 04-24-2025
- Dividend Yield
- TJX 1.33%
- GILD 3.02%
- EPS Growth
- TJX 10.36
- GILD N/A
- EPS
- TJX 4.26
- GILD 0.38
- Revenue
- TJX $56,360,000,000.00
- GILD $28,754,000,000.00
- Revenue This Year
- TJX $5.60
- GILD $1.80
- Revenue Next Year
- TJX $5.69
- GILD $3.83
- P/E Ratio
- TJX $29.96
- GILD $275.11
- Revenue Growth
- TJX 3.95
- GILD 6.04
- 52 Week Low
- TJX $92.35
- GILD $62.07
- 52 Week High
- TJX $131.30
- GILD $119.96
- Technical
- Relative Strength Index (RSI)
- TJX 58.79
- GILD 43.51
- Support Level
- TJX $125.53
- GILD $97.32
- Resistance Level
- TJX $131.30
- GILD $107.18
- Average True Range (ATR)
- TJX 4.53
- GILD 3.94
- MACD
- TJX 0.64
- GILD -0.45
- Stochastic Oscillator
- TJX 75.35
- GILD 41.42
About TJX TJX Companies Inc. (The)
TJX Companies is the leading off-price retailer of apparel, accessories, and home merchandise in the United States. The firm leverages its more than 20,000 global vendor relationships to procure and sell brand-name merchandise at prices 20%-60% cheaper than conventional retail channels. TJX opportunistically purchases excess inventory that stems from manufacturing overruns and retail closeout sales. The off-price retailer disperses its vast and disparate merchandise across its 5,000 global stores, creating a treasure-hunt shopping experience for consumers. Over three quarters of TJX's sales are derived from the United States, primarily via the T.J. Maxx, Marshalls, and HomeGoods banners. About 10% of sales are from Canada and 12% from Europe and Australia.
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).